The registration, importation and distribution of all heartburn medication containing ranitidine has been suspended in the UAE.
According to the Ministry of Health and Prevention (MoHAP), a circular was issued to health facilities and practitioners informing them about the move.
The decision is based on the recommendations of the US Food and Drug Administration (FDA) and other regulatory bodies regarding a possible contamination of the medicine with an impurity which is classified as potentially carcinogenic.
The Ministry says those wishing to stop taking medicine with ranitidine should consult a healthcare professional for a replacement.
Funeral prayer for Sheikh Ahmed bin Rashid to be held on Tuesday
Sheikh Ahmed bin Rashid Al Maktoum passes away; 10-day mourning in Dubai
Abu Dhabi to host UN congress on crime and criminal justice
Abu Dhabi strengthens greenhouse gas emissions monitoring
Sharjah Ruler approves 6,700 housing support requests
Abu Dhabi court secures AED 7.8 million in workers' dues
Sheikh Abdullah to lead UAE delegation at UN General Assembly
